National Bankshares Inc. (NASDAQ:NKSH) shares fell -1.68% in last trading session and ended the day at $33.26. NKSH has a return on assets of 1.70%. National Bankshares Inc. (NASDAQ:NKSH) quarterly performance is -7.59%.
On 25 February, National Bankshares Inc. (NASDAQ:NKSH) announced its results of operations for the three and twelve months ended December 31, 2015. The Company reported net income of $15.83 million for the twelve months ended December 31, 2015, a decrease from the $16.91 million earned in 2014. The 2015 return on average assets and return on average equity were 1.37% and 9.22%, respectively. Basic earnings per share in 2015 were $2.28. National Bankshares, Inc. ended 2015 with total assets of almost $1.20 billion.
Globus Medical, Inc. (NYSE:GMED) ended the last trading day at $24.30. Company weekly volatility is calculated as 3.27% and price to cash ratio as 9.70. Globus Medical, Inc. (NYSE:GMED) showed a weekly performance of 2.75%.
On 24 February, Globus Medical, Inc. (NYSE:GMED) announced its financial results for the fourth quarter and year ended December 31, 2015. Worldwide sales increased 14.8% as reported to $544.8 million, or 16.0% on a constant currency basis
EMC Corporation (NYSE:EMC) caters to the Technology space. It has a net profit margin of 8.10% and weekly performance is 3.28%. On the last day of trading company shares ended up at $26.13. EMC Corporation (NYSE:EMC) distance from 50-day simple moving average (SMA50) is 4.81%.
On 25 February, EMC Corporation (NYSE:EMC) has announced the new EMC provider Cloud System (PCS) a software designed to enable communications service providers to deliver distributed, multi-service, carrier-grade cloud solution economically and quickly.
Tredegar Corp. (NYSE:TG) shares moved up 10.64% in last trading session and ended the day at $13.73. TG Gross Margin is 14.70% and its has a return on assets of -1.80%. Tredegar Corp. (NYSE:TG) quarterly performance is -8.37%.
Tredegar Corp. (NYSE:TG) reported fourth-quarter financial results for the period ended December 31, 2015. Net sales in 2015 decreased by $78.8 million versus 2014, primarily due to lower volume from lost business and product transitions, and the unfavorable impact from the change in the U.S. dollar value of currencies for operations outside of the U.S.
Egalet Corporation (NASDAQ:EGLT) caters to the Healthcare space. Its weekly performance is -16.34%. On the last day of trading company shares ended up at $6.76. Egalet Corporation (NASDAQ:EGLT) distance from 50-day simple moving average (SMA50) is 0.87%.
Egalet Corporation (NASDAQ:EGLT) announced that the U.S. Food and Drug Administration (FDA) has accepted the new drug application (NDA) for ARYMO ER (morphine sulfate) extended-release tablets. ARYMO ER is being developed for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.
Leave a Reply